Surgery in Inflammatory Bowel Disease. Rajesh Gupta MS, MCh Surgical Gastroenterology Division Dept of General Surgery PGIMER, Chandigarh

Similar documents
Surgical Management of IBD. Val Jefford Grand Rounds October 14, 2003

Ileal Pouch Anal Anastomosis: The Preferred Method of Reconstruction after Proctocolectomy in Children

Surgical Management of IBD in the Age of Biologics

Homayoon Akbari, MD, PhD

Surgical Approach to Crohn s Colitis Segmental or Total Colectomy? Can We Avoid the Stoma?

SURGICAL MANAGEMENT OF ULCERATIVE COLITIS

Inflammatory Bowel Disease and Surgery: What You Should Know

Index. Surg Clin N Am 87 (2007) Note: Page numbers of article titles are in boldface type.

Index. Note: Page numbers of article title are in boldface type.

11/13/11. Biologics for CD and CUC: The Impact on Surgical Outcomes. Principles of Successful Intestinal Surgery

Surgery for Ulcerative Colitis 11/14/10. Colectomy for Ulcerative Colitis: What your patient should know. Surgery for Ulcerative Colitis

Colostomy & Ileostomy

Crohn s Disease. Resident Lecture 1/17/19

Inflammatory Bowel Disease: Updates and Controversies CASE #1 CASE #1 8/6/2015. What is the most likely diagnosis?

Surgical Therapies for the Treatment of IBD!

Surgery for Inflammatory Bowel Disease

Colorectal Surgery. Patient Care. Goals and Objectives

Inflammatory Bowel Disease When is diarrhea not just diarrhea?

The Role of Surgery in Inflammatory Bowel Disease. Cory D Barrat, MD Colon and Rectal Surgeon Mercy Health

Inflammatory Bowel Disease RTC 10/30/09

Surgical Treatment of Inflammatory Bowel Disease (IBD)

Perianal Fistula of Crohn s Disease

Index. Note: Page numbers of article titles are in boldface type.

Patho Basic Chronic Inflammatory Bowel Diseases. Jürg Vosbeck Pathology

Surgery and Crohn s. Crohn s Disease 70 % Why Operate? Complications of Disease. The Gastrointestinal Tract. Surgery for Inflammatory Bowel Disease

Beyond Anti TNFs: positioning of other biologics for Crohn s disease. Christina Ha, MD Cedars Sinai Inflammatory Bowel Disease Center

IBD 101. Ronen Stein, MD Assistant Professor of Clinical Pediatrics Division of Gastroenterology, Hepatology, and Nutrition

DIGESTIVE SYSTEM SURGICAL PROCEDURES December 22, 2015 (effective March 1, 2016) INTESTINES (EXCEPT RECTUM) Asst Surg Anae

Ileo-rectal anastomosis for Crohn's disease of

Perianal and Fistulizing Crohn s Disease: Tough Management Decisions. Jean-Paul Achkar, M.D. Kenneth Rainin Chair for IBD Research Cleveland Clinic

Benign anorectal diseases

Pouchitis and Cuffitis A bloody mess. Sze-Lin Peng Colorectal Surgeon Counties Manukau District Health Board

Percent Cumulative. Probability. Penetrating. Inflammatory. Stricturing. Months Patients at risk N =

IBD 101. Ronen Stein, MD Assistant Professor of Clinical Pediatrics Division of Gastroenterology, Hepatology, and Nutrition

Achieving Success in Ulcerative Colitis: the Role of Infliximab

Epidemiology / Morbidity

Ileoanal Pouch Solves the Problem

INFLAMMATORY BOWEL DISEASE. Jean-Paul Achkar, MD Center for Inflammatory Bowel Disease Cleveland Clinic

The role of Surgery and Stomas in IBD

Crohn's disease CAUSES COURSE OF CROHN'S DISEASE TREATMENT. Sulfasalazine

Laparoscopic Surgical Approaches for Ulcerative Colitis

PEDIATRIC INFLAMMATORY BOWEL DISEASE

Year 2002 Paper two: Questions supplied by Jo 1

Definitions. Clinical remission: Resolution of symptoms (stool frequency 3/day, no bleeding and no urgency)

This is the portion of the intestine which lies between the small intestine and the outlet (Anus).

Predicting the natural history of IBD. Séverine Vermeire, MD, PhD Department of Gastroenterology University Hospital Leuven Belgium

Citation for published version (APA): Bartels, S. A. L. (2013). Laparoscopic colorectal surgery: beyond the short-term effects

Surgery and Stomas in IBD When do I need it? Can I avoid it? How do I live with it?

ULCERATIVE COLITIS. Sean Lynch, MD and Richard Bloomfeld, MD Wake Forest University School of Medicine Winston-Salem, NC

Case Report Squamous Cell Carcinoma Originating from a Crohn s Enterocutaneous Fistula

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE

Surgical Outcomes of Crohn s Disease: A Single Institutional Experience in Taiwan. [J Soc Colon Rectal Surgeon (Taiwan) 2009;20:1-6]

SURGERY FOR COLITIS THE BOTTOM LINE

DIGESTIVE SYSTEM SURGICAL PROCEDURES May 1, 2015 INTESTINES (EXCEPT RECTUM) Asst Surg Anae

Mohamed EL-hemaly Gastro- intestinal surgical center, Mansoura University.

Fistulizing Crohn s Disease: The Aggressive Approach

, may spread caudally to present as a perianal abscess, laterally across the external sphincter to form an ischiorectal abscess or, rarely,

Case Report Successful Long-Term Use of Infliximab in Refractory Pouchitis in an Adolescent

The Road to Remission

Inflammatory Bowel Disease. Your Illness and Its Treatment

Acute Care Surgery: Diverticulitis

Treatment of Inflammatory Bowel Disease. Michael Weiss MD, FACG

THE CUTTING EDGE SURGERY FOR CROHN S DISEASE & ULCERATIVE COLITIS. crohnsandcolitis.ca

Case Presentations #2 Saturday November 13, Case #1 HPI 11/14/10. Uma Mahadevan-Velayos MD. Complicated Crohn s Pregnancy

children Crohn s disease in MR enterography for GI Complications Microscopy Characterization Primary sclerosing cholangitis Anorectal fistulae

How do I choose amongst medicines for inflammatory bowel disease. Maria T. Abreu, MD

Research Article Temporary Fecal Diversion in the Management of Colorectal and Perianal Crohn s Disease

Diarrhoea for the Acute Physician

An Unusual Complication of Crohn s Disease. Dr Gerald Busuttil Mr Debono s Firm Surgical Grand Round 25 th November 2008

Idiopathic inflammatory bowel disease is divided into 2 major disease processes, Crohn disease

Understanding Learning is the first step to getting help.

World Journal of Colorectal Surgery

Disclosure of Affiliations. The Way We Hope It Goes. Medicines and Surgery for IBD. None. Cases: Sweet and Not So Sweet

Case Conference. Craig Morgenthal Department of Surgery Long Island College Hospital

Citation for published version (APA): de Groof, E. J. (2017). Surgery and medical therapy in Crohn s disease: Improving treatment strategies

Inflammatory Bowel Disease

Adult organisational audit

Surgical strategies in paediatric inflammatory bowel disease

STOMA SITING & PARASTOMAL HERNIA MANAGEMENT

Modern Management of Perianal Fistulas in Crohn s Disease (PFCD): Future Directions

Surgical Workload, Outcome and Research Database: V1.1

Rectal Cancer. About the Colon and Rectum. Symptoms. Colorectal Cancer Screening

INFLAMMATORY BOWEL DISEASE

Understanding Inflammatory Bowel Diseases (IBD):

study was undertaken to assess the epidemiology, course and outcome of UC patients attending a hospital in Jordan.

St Mark's Hospital from 1953 to 1968

Chapter 34. Nursing Care of Patients with Lower Gastrointestinal Disorders

Guideline scope Diverticular disease: diagnosis and management

A Comparitive Study of Laying Open of Wound Vs Primary Closure In Fistula in Ano

What is Crohn's disease?

Indications for use of Infliximab

Staying Healthy as an IBD patient

Screening & Surveillance Guidelines

ORIGINAL ARTICLE. Surgery for Ulcerative Colitis in Elderly Persons. Changes in Indications for Surgery and Outcome Over Time

Treating Crohn s and Colitis in the ASC

LOOKING FOR AIR IN ALL THE WRONG PLACES Richard M. Gore, MD North Shore University Health System University of Chicago Evanston, IL

-2002: Rectal blood loss, UC? (no definite diagnosis) rectal mesalazine. -June 2008: Recurrence of rectal blood loss and urgency

Case discussion. Anastomotic leakage. intern superviser

Acute Diverticulitis. Andrew B. Peitzman, MD Mark M. Ravitch Professor of Surgery University of Pittsburgh

Transcription:

Surgery in Inflammatory Bowel Disease Rajesh Gupta MS, MCh Surgical Gastroenterology Division Dept of General Surgery PGIMER, Chandigarh 1

Ulcerative colitis (UC) Ulcerative colitis (UC) characterized by chronic inflammatory condition that affects the rectum and extends proximally into the colon for varying distances Many patients are treated effectively by a wide variety of medications Approx. 15 30% of patients require or elect operative intervention 2

Surgical Options in UC Complete removal of all potential disease bearing tissue theoretically curative Operative options Emergency: Total or subtotal abdominal colectomy with end ileostomy Elective : Total proctocolectomy with ileostomy Total proctocolectomy with IPAA All these procedures may be performed by using open or MIS techniques 3

Ulcerative Colitis Indications for Surgery Intractability : Failure to respond to medical therapy the most common indication Inability to control symptoms Poor quality of life Risks/Side effects of chronic medical therapy (especially long term corticosteroids) Noncompliance Growth failure Patients may opt for surgery in the elective or semi elective setting 4

Ulcerative Colitis Indications for Surgery contd Acute Colitis Clinical e/o actual or impending perforation Grade of Recommendation: 1B Surgery required in 20 30% of pts with toxic colitis, & typically consists of a subtotal colectomy with end ileostomy. 5

6

7

8

Acute Colitis contd Perforation in patients with Toxic Colitis a.w. high mortality 27 57%, regardless of whether the perforation is contained or free Mortality rate also increases as the time interval between perforation and surgery increases Pertinent to identify signs of impending perforation 9

Cecal Perforation 10

Cecal Perforation 11

Acute Colitis contd Signs of impending perforation Persistent or increasing colonic dilation Pneumatosis coli Worsening local peritonitis Development of MOF Signs may be masked by ongoing medical therapy 12

Acute Colitis contd Moderate to severe colitis Early surgical consultation should be obtained Grade of Recommendation: 1C Indications for surgical consultation in patients with a lesser degree of disease include Failure of primary therapy i.e., Pts. worsen on medical therapy or who do not make significant improvement after 48 96 hrs Pts. being considered for 2 nd line Monoclonal antibody (Infliximab, Adalimumab) or cyclosporine therapy 13

Acute Colitis contd Moderate to severe colitis Timing of surgery Patients with more than 8 stools per day 3 to 8 stools and a CRP > 45 mg/ml after 3 days of therapy 85% chance of requiring colectomy during same hospitalization Patients with contraindication to (or do not desire) MAb or cyclosporine therapy, or when steroids fail Persistent colonic distention Toxic Megacolon 14

Acute Colitis contd Moderate to severe colitis Important tips: Decision regarding response to 2 nd line or rescue therapy be made within 5 to 7 days after initiation Mortality rates increase as operative timing progresses from within 3 6 days (OR 2.12) & 11 days (OR 2.89) Longer waiting times results in Worsening physiological reserve Further depletion in nutrition stores Inappropriate delay in surgery with no apparent gain 15

UC Indications of Surgery Disabling Extra intestinal Manifestations Typically Episcleritis Erythema nodosum Aphthous ulcerations Large joint arthropathy These are more likely to be responsive to colectomy Hepatic, vascular, hematologic, cardiopulmonary, & neurological comorbidities Not responsive Growth failure in children another form of intractability may require colectomy 16

Ulcerative Colitis Indications for Surgery contd Risk of Malignancy Risk factors: Extent of colonic disease Pancolitis (proximal to the splenic flexure) Greater than left sided colitis Prolonged disease duration (>8 years with pancolitis) Diagnosis of UC at a younger age a.w. increased risk of colorectal cancer Additional risk factors include Family history of IBD Concomitant primary sclerosing cholangitis 17

Ulcerative Colitis Indications for Surgery contd Risk of Malignancy Patients with low grade dysplasia Total proctocolectomy, or surveillance endoscopy Grade of Recommendation: 1C Non adenoma like dysplasia associated lesion or mass High grade dysplasia Patients with carcinoma Total proctocolectomy, with or without IPAA Grade of Recommendation: 1B 18

Cut section: smooth tubularized left colon with loss of mucosal fold 19

Cut section tumor at lower end in ulcerative colitis 20

Ulcerative Colitis Indications for Surgery contd Colonic stricture : Develop in 5% to 10% with UC Especially with long standing disease Grade of Recommendation: 1B 25% of strictures malignant Most common manifestations of CRC in chronic UC Biopsy may reveal dysplasia or malignancy a negative biopsy not reliable: risk of sampling error and more infiltrative nature of colitis associated malignancies In general all patients with strictures should undergo an oncological resection 21

Surgery in UC Emergency Procedure Procedure of choice: Total or subtotal abdominal colectomy with end ileostomy Surgical goals in the acute setting To remove the bulk of the diseased bowel Restore patient health with the greatest reliability and least risk Preserve reconstructive options after the patient has recovered and medications are withdrawn Subtotal colectomy with end ileostomy and Hartmann closure of the distal bowel or creation of a mucous fistula a safe and effective approach Completion proctectomy and IPAA can be performed later to remove the remaining disease & restore intestinal continuity 22

Surgery in UC Elective Procedure 1. Total proctocolectomy with ileostomy considered a benchmark with which all other operations compared Suitable for those at significant risk for pouch failure Patients with impaired anal sphincter muscles Previous anoperineal disease Limited physiological reserve secondary to comorbid conditions 2. Total proctocolectomy with IPAA an appropriate op. for selected pt. Most commonly performed elective surgery A.w. acceptable morbidity rate (19 27 %) extremely low mortality rate (0.2 0.4 %) QOL approaches that of the healthy population Patient selection Baseline continence Ability to undergo major pelvic surgery and its complications Medical comorbidities 23

Proctocolectomy specimen 24

Cut Section Proctocolectomy Specimen 25

Pseudopolyps 26

27

28

Surgery in UC Post op Complications Risks arising from the pelvic dissection Infertility Sexual dysfunction Pouch specific complications Pouchitis Medical Rx to salvage pouch Antibiotics Immunomodulators Biologics Surgery Successful in more than 50% of cases Anastomotic leak Pelvic sepsis Fistula Stricture Cuff inflammation 29

Crohn s Disease Anywhere in GIT between the mouth and anus 50% have ileocolic disease 30% have ileal disease only 20% have colonic disease only 26.5% have perianal disease Felt to be a marker of more aggressive disease Vienna classification most commonly used (2000) Penetrating (fistulizing) Stricturing Nonpenetrating, nonstricturing disease 30

Crohn s Disease Indications of Surgery Tends to recur & cannot be cured Surgery is reserved for patients with Symptomatic disease refractory to medical management Or in those with complications : Retardation of growth in children Hemorrhage Perforation Abscess Fistula Stricture or Malignancy 31

Anorectal Crohn s Disease Large perianal skin tags with fissure Recurrent perirectal abscesses Complicated fistula in ano Strictures A careful anorectal examination (under anesthesia if necessary), including anoscopy and flexible sigmoidoscopy critical for diagnosis 32

CROHN S DISEASE Anal Fissure Typical anterior or posterior midline anal fissure Can be treated with standard medical treatments: Glyceryl trinitrate, Calcium channel blockers & Botulinum toxin Surgical Rx In absence of proctitis lateral internal anal sphincterotomy gives good results I.p.o. Proctitis Sphincterotomy be avoided 33

Abscess/Fistula in Ano/Rectovaginal Fistula EUA and drainage of abscesses in a timely fashion Incision as close to the anal verge as possible to minimize the risk of a long fistula tract Simple fistulas involving minimal muscle Fistulotomy with marsupialization of wound edges in patients with otherwise normal continence Repeat fistulotomy avoided : Risk of fecal incontinence Fistula in ano may have Internal opening above dentate line, Multiple internal openings, And/Or may involve a large amount (>50%) of the ext. anal sphincter Pelvic MRI or endorectal US with H 2 O 2 injected into the fistula tract can elucidate the anatomy of more complex fistulae 34

CROHN S DISEASE Fistula in Ano in CD Setons placed to control every internal opening Flexible sigmoidoscopy done to rule out proctitis Weak evidence anal fistula plug or the ligation of the intersphincteric fistula tract I.p.o proctitis Leave setons and continue with aggressive medical therapy to control rectal dis. Severe perianal disease refractory to setons Temporary or permanent fecal diversion (ileostomy vs colostomy) 35

CROHN S DISEASE Anorectal Stricture Can be extremely symptomatic Factors dictating therapy Presence or absence of Proctitis Exact location of stricture Anal stricture without anorectal inflamm. Dilated gently Anorectal strictures with severe proctitis refractory to medical Rx Proctectomy and end colostomy Rectal stricture without proctitis Initial attempt at dilation If it fails LAR & colo anal anastomosis 36

CROHN S DISEASE INTESTINAL FISTULA Patients often require multiple surgeries Function must be considered when deciding on the extent and aggressiveness of procedure 40 50% of patients require surgery < 10 years of diagnosis 16%, 28%, and 35% of patients require a second surgery at 5, 10, and 15 years after the first surgery respectively 37

CROHN S DISEASE INTESTINAL FISTULA Guiding Principles for surgery: 1.Nutrition should be optimized preop. if possible 2.Preop. esophagogastroduodenoscopy & colonoscopy are helpful. 3.CT enterography identifies both luminal & extraluminal intestinal dis. 4.Laparoscopy reasonable approach for complicated dis. 5.Only diseased bowel resected 6.Non diseased target of the fistula repaired safely 38

CROHN S DISEASE INTESTINAL FISTULA Guiding Principles for surgery (Contd.): 7. RM should be small (2 cm) & within grossly normal bowel 8. Increase the risk of anastomotic leak Steroid use (>10 mg of prednisone/day x 4 wks before surgery) Preop. abscess Although use of anti TNF biologics before surgery does not appear to increase the risk of a leak But still controversial with data supporting each side 39

CROHN S DISEASE Enteroenteric or Enterocolic Fistula Asymptomatic enteroenteric fistula should be left alone Large acute abscesses should be drained percutaneously if possible If fistula a.w. diarrhea Diseased bowel should be resected 40

CD Enterocutaneous Fistula Management Acute sepsis Treated with aggressive fluid resuscitation, iv antibiotics & drainage of large intra abdo. abscesses Skin opening should be pouched. Nutrition should be optimized Fistulogram or CT enterography helpful to delineate fistula anatomy Diseased bowel and fistula tract be resected 41

Diseased bowel with creeping fat and thickened mesentry 42

Surgery for bowel strictures Operative indications for stricturing dis. Persistent or recurrent obst. in the face of adequate medical management Significant weight loss Inability to tolerate a solid diet Inability to tolerate medication Inability to wean from steroids 43

Role of Preoperative TPN Severe malnutrition Moderate to severe Crohn s disease can improve their nutritional status and have significantly fewer postop. complications and mortality if treated for several weeks with hyperalimentation 44

CD Relevant Points in Patient s Course of Illness Reoperation rates for Crohn s disease approach 50% over the long term Smoking confers a 2.5 fold increased risk of postop. recurrence requiring surgery, and pts should be counseled extensivelyon smoking cessation techniques Every patient undergoing surgery should understand that there is some lifelong risk of intestinal failure and that bowel conservation is the goal Bowel sparing should be the guiding principle Pts. with IBD have a > 3 fold risk of VTE events in the postop. period 45

Carry Home Messsage UC Approx. 15 30% of patients of UC require or elect operative intervention Intractability : the most common indication Complete removal of all potential disease bearing tissue theoretically curative Surgery required in 20 30% of pts with toxic colitis High mortality 27 57% in perforation with toxic colitis Imperative to know signs of impending perforation Some disabling extra intestinal manifestations may respond to surgery Risk of Malignancy a.w. extent of colonic disease, prolonged disease duration (>8 years with pancolitis) and diagnosis at younger age 46

Carry Home Messsage CD 26.5% have perianal disease a marker of more aggressive disease Tends to recur & cannot be cured Surgical Rx of anorectal disease depends on presence or absence of proctitis Patients often require multiple surgeries Function must be considered when deciding on the extent and aggressiveness of procedure 40 50% of patients require surgery < 10 years of diagnosis 47

Thank you 48